KPRX
Kiora Pharmaceuticals
$1.76
−$0.60 (−25.42%)Oct 29, 2026
Key metrics
The numbers that frame KPRX today
- Market cap
- $7.79M
- ROIC
- -111.2%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.73
- 52wk High
- $2.91
Growth
Revenue and earnings trend for KPRX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about KPRX
Is Kiora Pharmaceuticals a good buy?
Hold. Kiora Pharmaceuticals has strong momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Kiora Pharmaceuticals is selling at a very high price.
What is the market capitalization of KPRX?
Kiora Pharmaceuticals's market capitalization is $7.79M.
What is the 52-week high for KPRX stock?
The 52-week high for Kiora Pharmaceuticals is $2.91. The current close of $1.76 is 39.5% below that high.
What is the 52-week low for KPRX stock?
The 52-week low for Kiora Pharmaceuticals is $1.73. The current close of $1.76 is 1.7% above that low.
Does KPRX stock pay dividends?
Kiora Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for KPRX?
Kiora Pharmaceuticals's Debt / Equity ratio is 0.02.